Business
The funds will be used to accelerate the company's innovation, expand its workforce and bolster support for applied behavior analysis providers.
The funds will be used to advance Insilico's drug pipeline and lab, which automates the research and development process, and refine its AI-enabled models and algorithms.
When it comes to claims review, AI allows things to be done much faster than humans with less errors, says Christine Stetler, AVP of Solution Engineering at MedeAnalytics.
The funds will be used to expand the U.S. and European reach of its FDA-cleared tinnitus treatment device, Lenire, including with the Department of Veterans Affairs.
The San Francisco-based digital musculoskeletal care company filed to go public on Monday and will list under the ticker symbol HNGE.
HIMSS25
While AI can perform complex tasks such as reading EHR screens and recommending ways to optimize processes, NYU Langone Health System's Dr. Jonah Feldman says it can't replace physicians' knowledge and training.
The company's population health revenue more than doubled from the $715,000 garnered in 2023. Syra also reported a 45% increase in YOY revenue and a net loss of $3.8 million.
The MSK company will use the funds to expand its value-based care initiatives and advance its technology and clinical programs.
HIMSS25
As healthcare organizations seek to increase patients' technology adoption, Natasha Ramontal, HIMSS senior digital health strategist, recommends leveraging existing tools like portals to offer a "one-stop shop" for services.
It is also expected to offer a new digital weight loss program.